TerraPower Isotopes® is deploying innovative expertise to create the next generation of isotopes and to support the advancement of technologies with the potential to change the face of oncology treatment.
TPI seeks to support revolutionary radiotherapies for treatments of cancers, such as prostate cancer, colorectal cancer, and non-Hodgkin’s lymphoma by supplying radioisotopes that currently cannot be accessed in amounts required to develop medical treatments. The Principal Radiochemist will support TPI’s efforts toward the long-term production of actinium 225, leveraging specific expertise and experience working with radionuclides at scales relevant to this goal.
This position interfaces with a dynamic interdisciplinary environment in which effective communication, team-work and collaboration is required, while maintaining composure to act safely, ensure quality of data, and enable timely decision-making. The position will require good judgement in ensuring regulatory compliance while delivering on commercial production and engineering design needs. The candidate must be capable of working closely with a focused and high achieving group, working with minimal day-to-day supervision, and relocating to the Everett, WA area.
For more information please visit:
Should you have any inquiries or require further information, please do not hesitate to reach out to schatterjee at terrapower.com,
Sayandev (Dev) Chatterjee, PhD; Manager, Innovation R&D Chemistry; Pronouns: he, him, his